These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cost effectiveness analysis in cystic fibrosis. Doran C; Vos T J Cyst Fibros; 2005 Dec; 4(4):211-2. PubMed ID: 16230054 [No Abstract] [Full Text] [Related]
7. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Ramsey DM; Wozniak DJ Mol Microbiol; 2005 Apr; 56(2):309-22. PubMed ID: 15813726 [TBL] [Abstract][Full Text] [Related]
8. Empirical therapy of infections in neutropenic patients. Gaya H Br J Haematol; 1998 May; 101 Suppl 1():5-9. PubMed ID: 9607734 [No Abstract] [Full Text] [Related]
19. Measurement of immunoglobulin G against Mycobacterial antigen A60 in patients with cystic fibrosis and lung infection due to Mycobacterium abscessus. Ferroni A; Sermet-Gaudelus I; Le Bourgeois M; Pierre-Audigier C; Offredo C; Rottman M; Guillemot D; Bernède C; Vincent V; Berche P; Gaillard JL Clin Infect Dis; 2005 Jan; 40(1):58-66. PubMed ID: 15614693 [TBL] [Abstract][Full Text] [Related]
20. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis. Hawley HB; Lewis RM; Swartz DR; Gump DW Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057 [No Abstract] [Full Text] [Related] [Next] [New Search]